Eligible patients had pathological diagnosis of translocation-related sarcoma , were aged 19 years or older , were unresponsive or intolerant to standard chemotherapy regimens , no more than four previous chemotherapy regimens , Eastern Cooperative Oncology Group performance status 0 or 1 , adequate bone marrow reserve , renal and liver functions , and had measurable lesions .